Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Exhaled breath analysis in the diagnosis of head and neck cancer.

Mäkitie AA, Almangush A, Youssef O, Metsälä M, Silén S, Nixon IJ, Haigentz M Jr, Rodrigo JP, Saba NF, Vander Poorten V, Ferlito A.

Head Neck. 2019 Dec 19. doi: 10.1002/hed.26043. [Epub ahead of print] Review.

PMID:
31854494
2.

Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance.

Saba NF, Chen ZG, Haigentz M, Bossi P, Rinaldo A, Rodrigo JP, Mäkitie AA, Takes RP, Strojan P, Vermorken JB, Ferlito A.

Mol Cancer Ther. 2019 Nov;18(11):1909-1915. doi: 10.1158/1535-7163.MCT-19-0214. Review.

PMID:
31676542
3.

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.

Argiris A, Li S, Savvides P, Ohr JP, Gilbert J, Levine MA, Chakravarti A, Haigentz M Jr, Saba NF, Ikpeazu CV, Schneider CJ, Pinto HA, Forastiere AA, Burtness B.

J Clin Oncol. 2019 Dec 1;37(34):3266-3274. doi: 10.1200/JCO.19.00555. Epub 2019 Oct 16.

PMID:
31618129
4.

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma.

Hamoir M, Schmitz S, Suarez C, Strojan P, Hutcheson KA, Rodrigo JP, Mendenhall WM, Simo R, Saba NF, D'Cruz AK, Haigentz M Jr, Bradford CR, Genden EM, Rinaldo A, Ferlito A.

Cancers (Basel). 2018 Aug 10;10(8). pii: E267. doi: 10.3390/cancers10080267. Review.

5.

Understanding Interactions of Smoking on Prognosis of HPV-Associated Oropharyngeal Cancers.

Haigentz M Jr, Suarez C, Strojan P, Rodrigo JP, Rinaldo A, Bradford CR, Corry J, Takes RP, Ferlito A.

Adv Ther. 2018 Mar;35(3):255-260. doi: 10.1007/s12325-018-0682-4. Epub 2018 Mar 6.

PMID:
29511982
6.

Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome.

Coca-Pelaz A, Takes RP, Hutcheson K, Saba NF, Haigentz M Jr, Bradford CR, de Bree R, Strojan P, Lund VJ, Mendenhall WM, Nixon IJ, Quer M, Rinaldo A, Ferlito A.

Adv Ther. 2018 Feb;35(2):153-160. doi: 10.1007/s12325-018-0663-7. Epub 2018 Feb 2. Review.

PMID:
29396681
7.

AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.

Fulcher CD, Haigentz M Jr, Ow TJ; Education Committee of the American Head and Neck Society (AHNS).

Head Neck. 2018 Apr;40(4):676-686. doi: 10.1002/hed.25025. Epub 2017 Nov 24. Review.

8.

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

de Bree R, Wolf GT, de Keizer B, Nixon IJ, Hartl DM, Forastiere AA, Haigentz M Jr, Rinaldo A, Rodrigo JP, Saba NF, Suárez C, Vermorken JB, Ferlito A.

Head Neck. 2017 Nov;39(11):2329-2349. doi: 10.1002/hed.24883. Epub 2017 Aug 17. Review.

9.

Multiple Endocrine and Neoplastic Diseases After Unsuccessful Treatment of Hepatitis C With Interferon and Ribavirin.

Attarian S, Sharma J, Kaubisch A, Zonszein J, Haigentz M Jr.

Am J Med Sci. 2017 Jul;354(1):66. doi: 10.1016/j.amjms.2016.10.001. Epub 2016 Oct 18. No abstract available.

PMID:
28755736
10.

Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy.

Saba NF, Mody MD, Tan ES, Gill HS, Rinaldo A, Takes RP, Strojan P, Hartl DM, Vermorken JB, Haigentz M Jr, Ferlito A.

Crit Rev Oncol Hematol. 2017 Jul;115:50-58. doi: 10.1016/j.critrevonc.2017.04.011. Epub 2017 Apr 27. Review.

PMID:
28602169
11.

Continuous Activity Monitoring During Concurrent Chemoradiotherapy.

Ohri N, Kabarriti R, Bodner WR, Mehta KJ, Shankar V, Halmos B, Haigentz M Jr, Rapkin B, Guha C, Kalnicki S, Garg M.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1061-1065. doi: 10.1016/j.ijrobp.2016.12.030. Epub 2016 Dec 25.

12.

Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer.

Li T, Piperdi B, Walsh WV, Kim M, Beckett LA, Gucalp R, Haigentz M Jr, Bathini VG, Wen H, Zhou K, Pasquinelli PB, Gajavelli S, Sreedhara M, Xie X, Lara PN Jr, Gandara DR, Perez-Soler R.

Clin Lung Cancer. 2017 Jan;18(1):60-67. doi: 10.1016/j.cllc.2016.10.003. Epub 2016 Oct 28.

13.

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.

Lee JY, Dhakal I, Casper C, Noy A, Palefsky JM, Haigentz M, Krown SE, Ambinder RF, Mitsuyasu RT.

J Cancer Epidemiol. 2016;2016:2138259. Epub 2016 Nov 2.

14.

Association between malignancy and non-alcoholic Wernicke's encephalopathy: a case report and literature review.

Choi EY, Gomes WA, Haigentz M Jr, Graber JJ.

Neurooncol Pract. 2016 Sep;3(3):196-207. doi: 10.1093/nop/npv036. Epub 2015 Sep 22.

15.

Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials.

Sanabria A, Chaves ALF, Kowalski LP, Wolf GT, Saba NF, Forastiere AA, Beitler JJ, Nibu KI, Bradford CR, Suárez C, Rodrigo JP, Strojan P, Rinaldo A, de Bree R, Haigentz M Jr, Takes RP, Ferlito A.

Auris Nasus Larynx. 2017 Feb;44(1):18-25. doi: 10.1016/j.anl.2016.06.005. Epub 2016 Jul 5. Review.

PMID:
27397024
16.

Cervical lymph node metastases from remote primary tumor sites.

López F, Rodrigo JP, Silver CE, Haigentz M Jr, Bishop JA, Strojan P, Hartl DM, Bradley PJ, Mendenhall WM, Suárez C, Takes RP, Hamoir M, Robbins KT, Shaha AR, Werner JA, Rinaldo A, Ferlito A.

Head Neck. 2016 Apr;38 Suppl 1:E2374-85. doi: 10.1002/hed.24344. Epub 2015 Dec 29. Review.

17.

Palliative Reconstruction for the Management of Incurable Head and Neck Cancer.

Miglani A, Patel VM, Stern CS, Weichman KE, Haigentz M Jr, Ow TJ, Garfein ES.

J Reconstr Microsurg. 2016 Mar;32(3):226-32. doi: 10.1055/s-0035-1568156. Epub 2015 Dec 4.

PMID:
26636886
18.

Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?

Samuels SE, Eisbruch A, Beitler JJ, Corry J, Bradford CR, Saba NF, van den Brekel MW, Smee R, Strojan P, Suárez C, Mendenhall WM, Takes RP, Rodrigo JP, Haigentz M Jr, Rapidis AD, Rinaldo A, Ferlito A.

Eur Arch Otorhinolaryngol. 2016 Oct;273(10):2877-94. doi: 10.1007/s00405-015-3771-x. Epub 2015 Oct 13. Review.

PMID:
26463714
19.

The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.

Smith RV, Schiff BA, Garg M, Haigentz M.

Laryngoscope. 2015 Nov;125 Suppl 10:S1-S15. doi: 10.1002/lary.25534. Epub 2015 Oct 5.

PMID:
26436491
20.

Diplopia and Ataxia in a Heavy Smoker.

Yang Y, Haigentz M Jr, Welch M.

JAMA. 2015 Sep 1;314(9):942-3. doi: 10.1001/jama.2015.8617. No abstract available.

PMID:
26325563
21.

The role of systemic therapy in the management of sinonasal cancer: A critical review.

Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, de Bree R, Rodrigo JP, Lopez F, Hanna EY, Haigentz M, Takes RP, Slootweg PJ, Silver CE, Rinaldo A, Ferlito A.

Cancer Treat Rev. 2015 Dec;41(10):836-43. doi: 10.1016/j.ctrv.2015.07.004. Epub 2015 Jul 31. Review.

PMID:
26255226
22.

Adenoid cystic carcinoma of the head and neck--An update.

Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A, Haigentz M Jr, Takes RP, Mondin V, Teymoortash A, Thompson LD, Ferlito A.

Oral Oncol. 2015 Jul;51(7):652-61. doi: 10.1016/j.oraloncology.2015.04.005. Epub 2015 May 2. Review.

PMID:
25943783
23.

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.

Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AW, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito A.

Head Neck. 2016 Apr;38 Suppl 1:E2151-8. doi: 10.1002/hed.24026. Epub 2015 Jul 14. Review.

24.

A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.

Gilbert J, Schell MJ, Zhao X, Murphy B, Tanvetyanon T, Leon ME, Neil Hayes D, Haigentz M Jr, Saba N, Nieva J, Bishop J, Sidransky D, Ravi R, Bedi A, Chung CH.

Oral Oncol. 2015 Apr;51(4):376-82. doi: 10.1016/j.oraloncology.2014.12.011. Epub 2015 Jan 13.

25.

Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention".

Saba NF, Haigentz M Jr, Vermorken JB, Strojan P, Bossi P, Rinaldo A, Takes RP, Ferlito A.

Oral Oncol. 2015 Feb;51(2):112-8. doi: 10.1016/j.oraloncology.2014.11.002. Epub 2014 Nov 26. Review.

PMID:
25434586
26.

Update on primary head and neck mucosal melanoma.

López F, Rodrigo JP, Cardesa A, Triantafyllou A, Devaney KO, Mendenhall WM, Haigentz M Jr, Strojan P, Pellitteri PK, Bradford CR, Shaha AR, Hunt JL, de Bree R, Takes RP, Rinaldo A, Ferlito A.

Head Neck. 2016 Jan;38(1):147-55. doi: 10.1002/hed.23872. Epub 2015 May 22. Review.

27.

A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer.

Camidge DR, Berge EM, Doebele RC, Ballas MS, Jahan T, Haigentz M Jr, Hoffman D, Spicer J, West H, Lee P, Yang L, Joshi A, Gao L, Yurasov S, Mita A.

J Thorac Oncol. 2014 Oct;9(10):1532-9. doi: 10.1097/JTO.0000000000000273.

28.

On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer.

Teymoortash A, Halmos GB, Silver CE, Strojan P, Haigentz M Jr, Rinaldo A, Ferlito A.

Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2597-600. doi: 10.1007/s00405-014-3203-3. Epub 2014 Jul 25. No abstract available.

PMID:
25060978
29.

Long-Term Disease Control in a Patient With Recurrent Bone-Only Oligometastatic Nasopharyngeal Carcinoma.

Khot A, Love C, Garg MK, Haigentz M Jr.

J Clin Oncol. 2016 Feb 1;34(4):e25-6. doi: 10.1200/JCO.2013.51.3549. Epub 2014 Jun 9. No abstract available.

PMID:
24912898
30.

Salivary mucoepidermoid carcinoma revisited.

Coca-Pelaz A, Rodrigo JP, Triantafyllou A, Hunt JL, Rinaldo A, Strojan P, Haigentz M Jr, Mendenhall WM, Takes RP, Vander Poorten V, Ferlito A.

Eur Arch Otorhinolaryngol. 2015 Apr;272(4):799-819. doi: 10.1007/s00405-014-3053-z. Epub 2014 Apr 26. Review.

PMID:
24771140
31.

Combined P16 and human papillomavirus testing predicts head and neck cancer survival.

Salazar CR, Anayannis N, Smith RV, Wang Y, Haigentz M Jr, Garg M, Schiff BA, Kawachi N, Elman J, Belbin TJ, Prystowsky MB, Burk RD, Schlecht NF.

Int J Cancer. 2014 Nov 15;135(10):2404-12. doi: 10.1002/ijc.28876. Epub 2014 Apr 17.

32.

Osteopoikilosis: A Benign Condition With the Appearance of Metastatic Bone Disease.

Ng C, Schwartzman L, Moadel R, Haigentz M Jr.

J Clin Oncol. 2015 Jun 20;33(18):e77-8. doi: 10.1200/JCO.2013.50.5222. Epub 2014 Mar 24. No abstract available.

PMID:
24663043
33.

When is chemotherapy in head and neck squamous cell carcinoma not indicated?

Haigentz M Jr, Vermorken JB, Forastiere AA, Corry J, Beitler JJ, Strojan P, Hartl DM, Rodrigo JP, Bradford CR, Rinaldo A, Takes RP, Mendenhall WM, Shaha AR, Wolf GT, Ferlito A.

Eur Arch Otorhinolaryngol. 2015 Apr;272(4):781-787. doi: 10.1007/s00405-014-2894-9. Epub 2014 Feb 14. No abstract available.

PMID:
24525999
34.

When is surgical therapy for head and neck malignant epithelial tumors not indicated?

Suárez C, Takes RP, Silver CE, Rodrigo JP, Strojan P, Woolgar JA, Haigentz M Jr, Hakan Coskun H, de Bree R, Owen RP, Elsheikh MN, Shaha AR, Rinaldo A, Ferlito A.

Eur Arch Otorhinolaryngol. 2015 Mar;272(3):513-6. doi: 10.1007/s00405-014-2895-8. Epub 2014 Feb 4. No abstract available.

PMID:
24493561
35.

Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.

Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AW, Haigentz M Jr, Beitler JJ, de Bree R, Takes RP, Paleri V, Kelly CG, Genden EM, Bradford CR, Harrison LB, Rinaldo A, Ferlito A.

Head Neck. 2015 Jan;37(1):134-50. doi: 10.1002/hed.23542. Epub 2014 Jan 31. Review.

36.

A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.

Rudek MA, Moore PC, Mitsuyasu RT, Dezube BJ, Aboulafia D, Gerecitano J, Sullivan R, Cianfrocca ME, Henry DH, Ratner L, Haigentz M Jr, Dowlati A, Little RF, Ivy SP, Deeken JF.

Cancer. 2014 Apr 15;120(8):1194-202. doi: 10.1002/cncr.28554. Epub 2014 Jan 28.

37.

When is reoperative surgery not indicated for recurrent head and neck squamous cell carcinoma?

Rodrigo JP, Kowalski LP, Silver CE, de Bree R, Rinaldo A, Shaha AR, Strojan P, Elsheikh MN, Haigentz M Jr, Sanabria A, Coskun HH, Takes RP, Ferlito A.

Eur Arch Otorhinolaryngol. 2015 Feb;272(2):259-62. doi: 10.1007/s00405-013-2828-y. Epub 2013 Nov 26. No abstract available.

PMID:
24276471
38.

Radiofrequency ablation in advanced head and neck cancer.

Owen RP, Lee JS, Silver CE, Bäck L, Beitler JJ, Rinaldo A, O'Malley BW Jr, Haigentz M Jr, Ferlito A.

Eur Arch Otorhinolaryngol. 2014 Feb;271(2):207-10. doi: 10.1007/s00405-013-2681-z. Epub 2013 Sep 24. No abstract available.

PMID:
24061569
39.

Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.

Salazar CR, Smith RV, Garg MK, Haigentz M Jr, Schiff BA, Kawachi N, Anayannis N, Belbin TJ, Prystowsky MB, Burk RD, Schlecht NF.

Head Neck Pathol. 2014 Mar;8(1):77-87. doi: 10.1007/s12105-013-0486-4. Epub 2013 Sep 4.

40.

Current questions in HIV-associated lung cancer.

Shcherba M, Shuter J, Haigentz M Jr.

Curr Opin Oncol. 2013 Sep;25(5):511-7. doi: 10.1097/CCO.0b013e328363dfdb. Review.

41.

Airway issues in anaplastic thyroid carcinoma.

Shaha AR, Ferlito A, Owen RP, Silver CE, Rodrigo JP, Haigentz M Jr, Mendenhall WM, Rinaldo A, Smallridge RC.

Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2579-83. doi: 10.1007/s00405-013-2556-3. Epub 2013 May 21. No abstract available.

PMID:
23689802
42.

Causes of death of patients with laryngeal cancer.

Ferlito A, Haigentz M Jr, Bradley PJ, Suárez C, Strojan P, Wolf GT, Olsen KD, Mendenhall WM, Mondin V, Rodrigo JP, Boedeker CC, Hamoir M, Hartl DM, Hunt JL, Devaney KO, Thompson LD, Rinaldo A, Takes RP.

Eur Arch Otorhinolaryngol. 2014 Mar;271(3):425-34. doi: 10.1007/s00405-013-2478-0. Epub 2013 Apr 17. Review.

PMID:
23591796
43.

Recent trends in the management of minor salivary gland carcinoma.

Vander Poorten V, Hunt J, Bradley PJ, Haigentz M Jr, Rinaldo A, Mendenhall WM, Suarez C, Silver C, Takes RP, Ferlito A.

Head Neck. 2014 Mar;36(3):444-55. doi: 10.1002/hed.23249. Epub 2013 Apr 4. Review.

PMID:
23559518
44.

The changing role of surgery in the current era of head and neck oncology.

Ferlito A, Takes RP, Silver CE, Strojan P, Haigentz M Jr, Robbins KT, Genden EM, Hartl DM, Shaha AR, Rinaldo A, Suárez C, Olsen KD.

Eur Arch Otorhinolaryngol. 2013 Jul;270(7):1971-3. doi: 10.1007/s00405-013-2353-z. No abstract available.

PMID:
23371537
45.

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors.

Saba NF, Yom SS, Haigentz M, El-Rayes B.

Chemother Res Pract. 2012;2012:291421. doi: 10.1155/2012/291421. Epub 2012 Dec 24. No abstract available.

46.

Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma.

Strojan P, Haigentz M Jr, Bradford CR, Wolf GT, Hartl DM, Langendijk JA, Rinaldo A, Eisbruch A, Mendenhall WM, Forastiere AA, Takes RP, Ferlito A.

Oral Oncol. 2013 Apr;49(4):283-6. doi: 10.1016/j.oraloncology.2012.11.002. Epub 2012 Dec 7. No abstract available.

PMID:
23219843
47.

Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma.

Digonnet A, Hamoir M, Andry G, Vander Poorten V, Haigentz M Jr, Langendijk JA, de Bree R, Hinni ML, Mendenhall WM, Paleri V, Rinaldo A, Werner JA, Takes RP, Ferlito A.

Eur Arch Otorhinolaryngol. 2013 Jul;270(7):1981-9. doi: 10.1007/s00405-012-2220-3. Epub 2012 Oct 26. Review.

PMID:
23100081
48.

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab.

Kono SA, Haigentz M Jr, Yom SS, Saba N.

Chemother Res Pract. 2012;2012:901320. doi: 10.1155/2012/901320. Epub 2012 Sep 27.

49.

Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management.

Abdullah SE, Haigentz M Jr, Piperdi B.

Chemother Res Pract. 2012;2012:351210. Epub 2012 Sep 11.

50.

The future of induction chemotherapy for head and neck squamous cell carcinoma.

Haigentz M Jr, Cohen EE, Wolf GT, Strojan P, Eisbruch A, Ferlito A.

Oral Oncol. 2012 Nov;48(11):1065-7. doi: 10.1016/j.oraloncology.2012.08.009. Epub 2012 Sep 14. No abstract available.

PMID:
22981388

Supplemental Content

Loading ...
Support Center